Addiction Medicine Journal Club

By Sonya Del Tredici and John Keenan

What's Addiction Medicine Journal Club about?

We believe that addiction is a disease that can be treated, and we want to help you stay up to date with the latest research that you can use in your addiction medicine practice.

Download our free app to listen on your phone

Addiction Medicine Journal Club episodes:

05.20.2024
41. Vaping for Smoking Cessation
In episode 41 we discuss vaping for smoking cessation. Auer R, Schoeni A, Humair JP, Jacot-Sadowski I, Berlin I, Stuber MJ, Haller ML, Tango RC, Frei A, Strassmann A, Bruggmann P, Baty F, Brutsche M, Tal K, Baggio S, Jakob J,...
05.06.2024
31-40 Round-Up
Quick summaries of Episodes 31-40. 31. Injection Drug Use Frequency Before and After Take-Home Naloxone Training 32. Trazodone for sleep disturbance in opioid dependent patients maintained on buprenorphine: A double blind, placebo-controlled trial 33. Non-fatal overdose risk associated with prescribing opioid agonists concurrently...
04.22.2024
40. BZD Prescriptions and Overdose Risk
In this episode we discuss drug overdose after benzodiazepine prescriptions for anxiety and depression. Bushnell GA, et al. Drug overdose risk with benzodiazepine treatment in young adults: Comparative analysis in privately and publicly insured individuals. Addiction. 2023. We also talk about the war on recovery treatments...
04.08.2024
39. Opioid Abstinence and Cognitive Function
In this episode we discuss improvements in cognitive function with opioid abstinence. Kaur, G. Et Al. Effects of Abstinence From Opioid on Neuropsychological Performance in Men With Opioid Use Disorder: A Longitudinal Study. Journal of Addiction Medicine 17(5): p 557-562, 9/10 2023. We...
03.25.2024
Articles that Changed Our Practice - Part 2
In this episode we discuss 5 more articles that changed our addiction medicine practice. Chambers LC, et al. Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl. JAMA Netw Open. 2023; 6(9):e2334540. September...
03.11.2024
Articles that Changed Our Practice - Part 1
In this episode we discuss 5 articles that changed our addiction medicine practice. Mahdi Sheikh, et al. Postdiagnosis Smoking Cessation and Reduced Risk for Lung Cancer Progression and Mortality: A Prospective Cohort Study. Ann Intern Med.2021;174:1232-1239. [Epub 27 July 2021]. (Episode 4) Santos GM, et...
02.26.2024
38. Rehab vs. Meds vs. No Treatment
In episode 38 we discuss an article comparing different treatments (and no treatment) for opioid use disorder. Robert Heimer, Anne C. Black, Hsiuju Lin, Lauretta E. Grau, David A. Fiellin, Benjamin A. Howell, Kathryn Hawk, Gail D’Onofrio, William C. Becker. Receipt...
02.05.2024
37. Injectable Vs. Sublingual Buprenorphine
37. Injectable Vs. Sublingual Buprenorphine In episode 37 we discuss an article comparing injectable and sublingual buprenorphine. Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial. Marsden, John et...
01.15.2024
36. FOMO and Smartphone Use
In episode 36 we discuss an article about the mediators of problematic smartphone use. Christiane Arrivillaga, Caleb J. Hallauer, Christian Montag, Jon D. Elhai. Emotion dysregulation factors associated with problematic smartphone use severity: The mediating role of fear of missing out....
01.01.2024
35. Prior Auths and Buprenorphine
In episode 35 we discuss whether eliminating prior auths leads to more buprenorphine prescribing. Christine PJ, Larochelle MR, Lin L, McBride J, Tipirneni R. Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder. JAMA Health Forum. 2023;4(10):e233549. We also discuss buprenorphine diversion, and the...
12.18.2023
34. 24 mg of Buprenorphine
In episode 24 we discuss prescribing 24 mg of buprenorphine daily. Chambers LC, Hallowell BD, Zullo AR, et al. Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl. JAMA Netw Open. 2023;6(9):e2334540. September 2023. We also discuss why...
12.04.2023
33. Polypharmacy and Overdose
In episode 33 we discuss overdose risk and polypharmacy: opioids, benzodiazepines, antipsychotics, and gabapentinoids. Domzaridou E, Carr MJ, Millar T, Webb RT, Ashcroft DM. Non-fatal overdose risk associated with prescribing opioid agonists concurrently with other medication: Cohort study conducted using linked...
11.20.2023
32. Trazodone for Sleep in OUD
In episode 32 we discuss an article about trazodone for sleep in people with opioid use disorder on buprenorphine. Piyush Goyal, Dheeraj Kattula, Ravindra Rao, Roshan Bhad, Ashwani Kumar Mishra, Anju Dhawan. Trazodone for sleep disturbance in opioid dependent patients maintained...
11.06.2023
31. Naloxone and IV Drug Use
31: We discuss an article about how naloxone training impacts IV drug use. Colledge-Frisby S, Rathnayake K, Nielsen S, et al. Injection Drug Use Frequency Before and After Take-Home Naloxone Training. JAMA Netw Open. 2023;6(8):e2327319. We also discuss gambling self-exclusion and which professions use the most...
10.23.2023
21-30 Round-Up
Quick summaries of Episodes 21-30. 21. SOAT for OUD: Short-Acting Opioid Agonists for Opioid Use Disorder: Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder 22. Contingency Management for Coronary Artery Disease: High-risk Coronary Plaque Regression...
10.09.2023
30. Race and MOUD
In episode 30 we discuss an article about racial differences in the receipt of medications for opioid use disorder. Barnett ML, Meara E, Lewinson T, Hardy B, Chyn D, Onsando M, Huskamp HA, Mehrotra A, Morden NE. Racial Inequality in Receipt...
09.25.2023
29. Vaping Cessation
In episode 29 we discuss an article about using varenicline and counseling for vaping cessation.. Caponnetto, P., Campagna, D., Ahluwalia, J.S. et al. Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial. BMC Med 21, 220 (2023). In other vaping-related news: From NYSCSH: Vape...
09.11.2023
28. Pain and Recovery
In episode 28 we discuss an article about pain and addiction recovery. Ajay Manhapra, Elina A. Stefanovics, Taeho Greg Rhee, Robert A. Rosenheck, Persistence of significant pain interference following substance use disorder remission: Negative association with psychosocial and physical recovery, Drug...
08.28.2023
27. The First Opioid Prescription
In episode 27 we discuss an article about the risk of developing opioid use disorder after the first opioid prescription. Kendler, K., Lönn, S., Ektor-Andersen, J., Sundquist, J., & Sundquist, K. (2022). Risk factors for the development of opioid use disorder...
08.15.2023
26. Addiction Survivors
26. We discuss a new conceptual model of addiction recovery. Pytell, J.D., Chander, G., Thakrar, A.P. et al. Pytell, J.D., Chander, G., Thakrar, A.P. et al. Does a Survivorship Model of Opioid Use Disorder Improve Public Stigma or Policy Support? A General Population Randomized Experiment. J...
07.17.2023
25. High-dose Buprenorphine Induction
25. We discuss an article about high-dose buprenorphine induction. Herring AA, Vosooghi AA, Luftig J, et al. High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder. JAMA Netw Open. 2021;4(7):e2117128. From NPR: Drugmaker Mallinckrodt may renege on $1.7...
07.03.2023
24. Smoking Cessation and Mortality
24. We discuss updated data on the harms of smoking and the benefits of quitting. Thomson B, Emberson J, Lacey B, et al. Association Between Smoking, Smoking Cessation, and Mortality by Race, Ethnicity, and Sex Among US Adults. JAMA Netw Open. 2022;5(10):e2231480. We also...
06.19.2023
23. Eat-Sleep-Console
23. We discuss an article about the Eat-Sleep-Console approach to treat neonatal opioid withdrawal syndrome. Young LW, Ounpraseuth ST, et. al. ACT NOW Collaborative. Eat, Sleep, Console Approach or Usual Care for Neonatal Opioid Withdrawal. N Engl J Med. 2023 Apr...
06.05.2023
22. Contingency Management for Coronary Artery Disease
22. Contingency Management for Coronary Artery Disease 22: We discuss an article about contingency management and the regression of coronary plaques in HIV+ cocaine users. Lai, Hong PhD; Bluemke, David A. MD; Fishman, Elliot K. MD; Gerstenblith, Gary MD; Celentano, David D....
05.22.2023
21. SOAT for OUD: Short-Acting Opioid Agonists for Opioid Use Disorder
21: We discuss an article about using short-acting opioids to treat opioid use disorder in the hospital. Thakrar, A.P., Uritsky, T.J., Christopher, C. et al. Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder. Addict Sci...
05.08.2023
What We Learned at ASAM2023
What We Learned at ASAM2023 In this episode, we share what we learned at the 2023 American Society of Addiction Medicine Conference. Some links from the conference that you might like: Curbsiders Addiction Medicine Podcast ToxIC: Toxicology Investigators Consortium DrugsData from the Erowid Center CESAR: Center...
04.24.2023
11-20 Round-up
11-20 Round-up Super busy? Here are quick summaries of the last 10 articles. Article list: 11. Impact of wine bottle and glass sizes on wine consumption at home: a within- and between- households randomized controlled trial 12. Association of Methamphetamine and Opioid Use With...
04.10.2023
20. Targeted Naltrexone for Binge Drinking
20. Targeted Naltrexone for Binge Drinking In episode 20 we discuss an article about taking naltrexone as needed to reduce binge drinking among sexual and gender minority men. Santos GM, Ikeda J, Coffin P, Walker J, Matheson T, Ali A, McLaughlin M,...
03.29.2023
19. Patients’ Goals in Treatment
19. Patients’ Goals in Treatment In episode 19 we discuss an article about what is most important to patients in treatment for opioid use disorder. Reed, M.K., Smith, K.R., Ciocco, F. et al. Sorting through life: evaluating patient-important measures of success in...
03.13.2023
18. Treating HCV in People Who Inject Drugs
In episode 18 we discuss the Hepatitis C Real Option (HERO) Study about two different models of HCV treatment in people who inject drugs. Litwin AH, Lum PJ, Taylor LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, Heo...
02.27.2023
17. Bup-nalox vs. Bup in Pregnancy
In episode 17 we discuss buprenorphine-naloxone vs. buprenorphine alone in pregnancy. Perry, Briana N. MD; Vais, Simone MD; Boateng, Jeffery O. MBchB, MPH; Jain, Mayuri MPH; Wachman, Elisha M. MD; Saia, Kelley A. MD. Buprenorphine-naloxone Versus Buprenorphine for Treatment of Opioid...
02.13.2023
16. Treating Opioid Use Disorder in Jail
16. Treating Opioid Use Disorder in Jail In episode 16 we discuss an article about in-jail medication for opioid use disorder and recidivism. Elizabeth A. Evans, Donna Wilson, Peter D. Friedmann. Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder....
01.30.2023
15. Buprenorphine vs. Methadone in Pregnancy
In episode 15 we discuss buprenorphine vs. methadone in pregnancy. E.A. Suarez, K.F. Huybrechts, L. Straub, S. Hernández‑Díaz, H.E. Jones, H.S. Connery, J.M. Davis, K.J. Gray, B. Lester, M. Terplan, H. Mogun, and B.T. Bateman. Buprenorphine versus Methadone for Opioid Use...
01.09.2023
14. Early Life Trauma and Opioid Use Disorder
In episode 14 we discuss the connection between early life trauma, depression, anxiety, stress, and opioid use disorder. Effects of Early Life Trauma on Risks for Adult Opioid Use Disorder Are Mediated by Stress and Occur Independent of Depression and Anxiety....
01.02.2023
13. Prescription Opioids and Cognitive Decline
In episode 13 we discuss opioids and cognitive changes in older adults. Warner, NS, Hanson, AC, Schulte, PJ, Habermann, EB, Warner, DO, Mielke, MM. Prescription opioids and longitudinal changes in cognitive function in older adults: A population-based observational study. J Am...
12.19.2022
12. Methamphetamine and Opioid Overdose in Rural Communities
In episode 12 we discuss overdoses related to methamphetamine and opioid use in rural areas. Korthuis PT, Cook RR, Foot CA, et al. Association of Methamphetamine and Opioid Use With Nonfatal Overdose in Rural Communities. JAMA Netw Open. 2022;5(8):e2226544. doi:10.1001/jamanetworkopen.2022.26544 August...
12.05.2022
11. Wine Bottle and Wineglass Size
In episode 11 we discuss an article about the impact of wine bottle and glass size on consumption. Mantzari, E, Ventsel, M, Ferrar, J, Pilling, MA, Hollands, GJ, Marteau, TM. Impact of wine bottle and glass sizes on wine consumption at...
11.21.2022
1-10. Round-up
Short on time? In this episode we give you quick summaries of articles 1-10. Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder Association of...
11.07.2022
10. Buprenorphine Tapering
In episode 10 we discuss an article about buprenorphine tapering. Bozinoff N, Men S, Kurdyak P, Selby P, Gomes T. Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper. JAMA Netw Open. 2022;5(9):e2234168. ---------- Take a look at Riggs, KR, DeRussy, AJ, Leisch,...
10.24.2022
9. Psilocybin for Alcohol Use Disorder
In episode 9 we discuss psilocybin for treating alcohol use disorder. Bogenschutz MP, Ross S, Bhatt S, et al. Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized...
10.10.2022
8. Opioid Tapering and Risk of Suicide and Overdose
In episode 8 we discuss the article about opioid tapering and discontinuation, and the risks of suicide and overdose. Larochelle MR, Lodi S, Yan S, Clothier BA, Goldsmith ES, Bohnert ASB. Comparative Effectiveness of Opioid Tapering or Abrupt Discontinuation vs No...
09.26.2022
7. Treating Opioid and Polysubstance Use Disorders
In Episode 7 we discuss treating opioid use disorder with co-occurring polysubstance use. Xu KY, Mintz CM, Presnall N, Bierut LJ, Grucza RA. Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use. JAMA Netw Open....
09.12.2022
6. A BZD-Sparing Alcohol Withdrawal Protocol
In episode 6 we discuss a benzodiazepine-sparing alcohol withdrawal protocol. Smith JT, Sage M, Szeto H, et al. Outcomes After Implementation of a Benzodiazepine-Sparing Alcohol Withdrawal Order Set in an Integrated Health Care System. JAMA Netw Open. 2022;5(2):e220158. 2022 Feb 2. We...
08.29.2022
5. Clinical Effects of Medical Marijuana Cards
Episode 5 discusses the clinical effects of getting a medical marijuana card. Gilman JM, Schuster RM, Potter KW, et al. Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial. JAMA Netw...
08.15.2022
4. Smoking Cessation After Lung Cancer Diagnosis
Episode 4 discusses the benefits of smoking cessation after a diagnosis of lung cancer. Mahdi Sheikh, Anush Mukeriya, Oxana Shangina, et al. Postdiagnosis Smoking Cessation and Reduced Risk for Lung Cancer Progression and Mortality: A Prospective Cohort Study. Ann Intern Med.2021;174:1232-1239....
08.02.2022
3. Opioid Tapering and Overdoses and Mental Health Crises
In episode 3 we discuss the risks of tapering for patients on long-term, high-dose opioids. Article citation: Agnoli, A., Xing, G., Tancredi, D. J., Magnan, E., Jerant, A., & Fenton, J. Association of Dose Tapering With Overdose or Mental Health Crisis...
08.02.2022
2: Prescribing Stimulants for Patients on Buprenorphine
In episode 2 we discuss the safety of prescribing stimulants for patients receiving buprenorphine. Article Citation: Mintz CM, Xu KY, Presnall NJ, et al. Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder....
07.04.2022
1. The Cardiovascular Effects of Alcohol
In Episode 1 we discuss the article “Association of Habitual Alcohol Intake with Risk of Cardiovascular Disease,” a reexamination of the question of how alcohol intake is related to cardiovascular outcomes, and whether or not the J-curve for risks of...

What's Addiction Medicine Journal Club about?

Download our free app to listen on your phone

Addiction Medicine Journal Club episodes:

41. Vaping for Smoking Cessation

31-40 Round-Up

40. BZD Prescriptions and Overdose Risk

39. Opioid Abstinence and Cognitive Function

Articles that Changed Our Practice - Part 2

Articles that Changed Our Practice - Part 1

38. Rehab vs. Meds vs. No Treatment

37. Injectable Vs. Sublingual Buprenorphine

36. FOMO and Smartphone Use

35. Prior Auths and Buprenorphine

34. 24 mg of Buprenorphine

33. Polypharmacy and Overdose

32. Trazodone for Sleep in OUD

31. Naloxone and IV Drug Use

21-30 Round-Up

30. Race and MOUD

29. Vaping Cessation

28. Pain and Recovery

27. The First Opioid Prescription

26. Addiction Survivors

25. High-dose Buprenorphine Induction

24. Smoking Cessation and Mortality

23. Eat-Sleep-Console

22. Contingency Management for Coronary Artery Disease

21. SOAT for OUD: Short-Acting Opioid Agonists for Opioid Use Disorder

What We Learned at ASAM2023

11-20 Round-up

20. Targeted Naltrexone for Binge Drinking

19. Patients’ Goals in Treatment

18. Treating HCV in People Who Inject Drugs

17. Bup-nalox vs. Bup in Pregnancy

16. Treating Opioid Use Disorder in Jail

15. Buprenorphine vs. Methadone in Pregnancy

14. Early Life Trauma and Opioid Use Disorder

13. Prescription Opioids and Cognitive Decline

12. Methamphetamine and Opioid Overdose in Rural Communities

11. Wine Bottle and Wineglass Size

1-10. Round-up

10. Buprenorphine Tapering

9. Psilocybin for Alcohol Use Disorder

8. Opioid Tapering and Risk of Suicide and Overdose

7. Treating Opioid and Polysubstance Use Disorders

6. A BZD-Sparing Alcohol Withdrawal Protocol

5. Clinical Effects of Medical Marijuana Cards

4. Smoking Cessation After Lung Cancer Diagnosis

3. Opioid Tapering and Overdoses and Mental Health Crises

2: Prescribing Stimulants for Patients on Buprenorphine

1. The Cardiovascular Effects of Alcohol

Other shows like Addiction Medicine Journal Club: